Laman Utama8AK • FRA
add
Alkermes Plc
Tutup sebelumnya
€26.80
Julat hari
€27.40 - €27.80
Julat tahun
€20.80 - €34.60
Permodalan pasaran
5.18B USD
Bilangan Purata
1.00
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Mac 2025info | Perubahan T/T |
|---|---|---|
Hasil | 306.51J | -12.52% |
Perbelanjaan pengendalian | 243.52J | -1.97% |
Pendapatan bersih | 22.46J | -39.00% |
Margin untung bersih | 7.33 | -30.26% |
Pendapatan bagi setiap syer | 0.29 | -32.33% |
EBITDA | 21.21J | -58.70% |
Kadar cukai berkesan | 11.87% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Mac 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 884.02J | 18.65% |
Jumlah aset | 2.08B | -1.97% |
Jumlah liabiliti | 570.39J | -34.37% |
Jumlah ekuiti | 1.51B | — |
Syer tertunggak | 164.90J | — |
Harga kepada buku | 2.92 | — |
Pulangan pada aset | 1.67% | — |
Pulangan pada modal | 2.21% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Mac 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 22.46J | -39.00% |
Tunai daripada operasi | 98.81J | 368.12% |
Tunai daripada pelaburan | 9.10J | 122.78% |
Tunai daripada pembiayaan | 747.00K | 104.18% |
Perubahan bersih dalam tunai | 108.66J | 395.95% |
Aliran tunai bebas | 75.80J | 536.44% |
Perihal
Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall. In September 2011 Alkermes, Inc. merged with Elan Drug Technologies, the former drug formulation and manufacturing division of Élan Corporation, plc. The company is headquartered in Dublin, and has an R&D center in Waltham, Massachusetts, and a manufacturing facility in Wilmington, Ohio. Wikipedia
Diasaskan
1987
Tapak web
Pekerja
1,800
